Literature DB >> 9932376

AMPA receptors: molecular and functional diversity.

K Borges1, R Dingledine.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9932376     DOI： 10.1016/s0079-6123(08)60436-7

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN： 0079-6123            Impact factor:   2.453


× No keyword cloud information.
  30 in total

1.  Long-term specification of AMPA receptor properties after synapse formation.

Authors:  J J Lawrence; L O Trussell
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

Review 2.  Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date.

Authors:  Daniel C Mathews; Ioline D Henter; Carlos A Zarate
Journal:  Drugs       Date:  2012-07-09       Impact factor: 9.546

3.  Group I mGluRs and long-term depression: potential roles in addiction?

Authors:  Brad A Grueter; Zoé A McElligott; Danny G Winder
Journal:  Mol Neurobiol       Date:  2007-07-27       Impact factor: 5.590

4.  The type II cGMP dependent protein kinase regulates GluA1 levels at the plasma membrane of developing cerebellar granule cells.

Authors:  Salvatore Incontro; Francisco Ciruela; Edward Ziff; Franz Hofmann; José Sánchez-Prieto; Magdalena Torres
Journal:  Biochim Biophys Acta       Date:  2013-03-29

Review 5.  Research Progress on Alzheimer's Disease and Resveratrol.

Authors:  Yan Yan; Huihuang Yang; Yuxun Xie; Yuanlin Ding; Danli Kong; Haibing Yu
Journal:  Neurochem Res       Date:  2020-03-11       Impact factor: 3.996

6.  Knockdown of GluA2 induces apoptosis in non-small-cell lung cancer A549 cells through the p53 signaling pathway.

Authors:  Hong-Yan Zhang; Wei Yang; Ji-Bin Lu
Journal:  Oncol Lett       Date:  2017-05-24       Impact factor: 2.967

Review 7.  Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders.

Authors:  Rodrigo Machado-Vieira; Giacomo Salvadore; Lobna A Ibrahim; Nancy Diaz-Granados; Carlos A Zarate
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

8.  Specificity protein 4 (Sp4) regulates the transcription of AMPA receptor subunit GluA2 (Gria2).

Authors:  Anusha Priya; Kaid Johar; Bindu Nair; Margaret T T Wong-Riley
Journal:  Biochim Biophys Acta       Date:  2014-02-24

Review 9.  Bipolar disorder: candidate drug targets.

Authors:  Carlos A Zarate; Husseini K Manji
Journal:  Mt Sinai J Med       Date:  2008 May-Jun

Review 10.  Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders.

Authors:  Gerard Sanacora; Carlos A Zarate; John H Krystal; Husseini K Manji
Journal:  Nat Rev Drug Discov       Date:  2008-05       Impact factor: 84.694
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.